文献速递神经肿瘤

NF2突变与2级和3级复发脑膜瘤对放疗的抵抗相关

NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
PubMed 文献 · J Neurooncol · 2022-11-27

本研究从机构组织库纳入53例2级和3级复发脑膜瘤患者(29例NF2野生型、24例NF2突变型),其中19例接受术后放疗,回顾性分析至影像学复发时间。NF2野生型患者术后放疗与复发风险降低78%相关(HR 0.216;95%CI 0.068-0.682;p=0.009);NF2突变型患者术后放疗与复发风险非显著升高相关(HR 2.43;95%CI 0.88-6.73;p=0.087)。

要点

  • NF2野生型复发高级别脑膜瘤术后放疗与复发风险降低78%相关(HR 0.216;95%CI 0.068-0.682;p=0.009)。
  • NF2突变型患者术后放疗与复发风险非显著升高相关(HR 2.43;95%CI 0.88-6.73;p=0.087)。
  • NF2可能作为术后放疗决策中有价值的预后标志物,需进一步前瞻性研究验证。

核心结论

  • 本研究显示术后放疗对NF2野生型复发高级别脑膜瘤患者具有保护效应。
  • 术后放疗在NF2突变型肿瘤中可能与无改善甚至复发时间加速相关。
  • 复发率的差异提供证据表明NF2可能是术后放疗治疗决策中有价值的预后标志物。
  • 需要进一步前瞻性研究验证这一关系。

研究设计与样本

  • 从机构组织库中识别具有超过30天术后随访且链接靶向下一代测序的2级和3级复发脑膜瘤。
  • 通过回顾性审查确定至影像学复发的时间。
  • 使用Cox回归按NF2突变状态分层估计接受术后放疗患者的调整复发风险。
  • 共纳入53例非典型和间变性脑膜瘤(29例NF2野生型、24例NF2突变型),其中19例接受术后放疗。

主要发现

  • 按NF2野生型分层,NF2野生型患者术后放疗与复发风险降低78%相关(HR 0.216;95%CI 0.068-0.682;p=0.009)。
  • 按NF2突变分层,NF2突变型患者接受术后放疗与未接受者相比,复发风险非显著升高(HR 2.43;95%CI 0.88-6.73;p=0.087)。

局限性

  • 原文未报告局限性。
  • 原文结论指出需要进一步前瞻性研究验证这一关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: High grade meningiomas have a prognosis characterized by elevated recurrence rates and radiation resistance. Recent work has highlighted the importance of genomics in meningioma prognostication. This study aimed to assess the relationship between the most common meningioma genomic alteration (NF2) and response to postoperative radiation therapy (RT). METHODS: From an institutional tissue bank, grade 2 and 3 recurrent meningiomas with both > 30 days of post-surgical follow-up and linked targeted next-generation sequencing were identified. Time to radiographic recurrence was determined with retrospective review. The adjusted hazard of recurrence was estimated using Cox-regression for patients treated with postoperative RT stratified by NF2 mutational status. RESULTS: Of 53 atypical and anaplastic meningiomas (29 NF2 wild-type, 24 NF2 mutant), 19 patients underwent postoperative RT. When stratified by NF2 wild-type, postoperative RT in NF2 wild-type patients was associated with a 78% reduction in the risk of recurrence (HR 0.216; 95%CI 0.068-0.682; p = 0.009). When stratified by NF2 mutation, there was a non-significant increase in the risk of recurrence for NF2 mutant patients who received postoperative RT compared to those who did not (HR 2.43; 95%CI 0.88-6.73, p = 0.087). CONCLUSION: This study demonstrated a protective effect of postoperative RT in NF2 wild-type patients with recurrent high grade meningiomas. Further, postoperative RT may be associated with no improvement and perhaps an accelerated time to recurrence in NF2 mutant tumors. These differences in recurrence rates provide evidence that NF2 may be a valuable prognostic marker in treatment decisions regarding postoperative RT. Further prospective studies are needed to validate this relationship.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Vasan V, Dullea JT, Devarajan A, et al. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas. J Neurooncol. 2022. PMID: 36436149. doi:10.1007/s11060-022-04197-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。